These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 34407780)
1. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants. Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780 [TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
3. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design. Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495 [TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial. Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280 [TBL] [Abstract][Full Text] [Related]
5. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499 [TBL] [Abstract][Full Text] [Related]
6. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161 [TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177 [TBL] [Abstract][Full Text] [Related]
8. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357 [TBL] [Abstract][Full Text] [Related]
9. Multitarget Stool RNA Test for Colorectal Cancer Screening. Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871 [TBL] [Abstract][Full Text] [Related]
10. Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study. Schult AL; Botteri E; Hoff G; Randel KR; Dalén E; Eskeland SL; Holme Ø; de Lange T BMJ Open; 2021 Jul; 11(7):e048183. PubMed ID: 34210732 [TBL] [Abstract][Full Text] [Related]
11. Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening. Randel KR; Botteri E; Romstad KMK; Frigstad SO; Bretthauer M; Hoff G; de Lange T; Holme Ø Gastroenterology; 2019 May; 156(6):1642-1649.e1. PubMed ID: 30689972 [TBL] [Abstract][Full Text] [Related]
12. Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study. Dong X; Du L; Luo Z; Xu Y; Wang C; Wang F; Cao W; Zhao L; Zheng Y; Zhu H; Xia C; Li J; Du M; Hang D; Ren J; Shi J; Shen H; Chen W; Li N; He J; PLoS Med; 2024 Feb; 21(2):e1004340. PubMed ID: 38386617 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial. Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G; Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125 [TBL] [Abstract][Full Text] [Related]
14. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129 [TBL] [Abstract][Full Text] [Related]
15. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study. Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia]. Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824 [No Abstract] [Full Text] [Related]
18. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT). Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185 [TBL] [Abstract][Full Text] [Related]
19. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. Johnson DA; Barclay RL; Mergener K; Weiss G; König T; Beck J; Potter NT PLoS One; 2014; 9(6):e98238. PubMed ID: 24901436 [TBL] [Abstract][Full Text] [Related]
20. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives. Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196 [No Abstract] [Full Text] [Related] [Next] [New Search]